Breast tumour stroma is a prognostic indicator and target for therapy.
Affiliation
Breakthrough Breast Cancer Research Unit, Paterson Institute for Cancer Research, University of Manchester, The Christie NHS Foundation Trust, University Hospital of South Manchester, Manchester M20 4BX, UK. Anthony.Howell@christie.nhs.ukIssue Date
2009
Metadata
Show full item recordCitation
Breast tumour stroma is a prognostic indicator and target for therapy. 2009, 11 Suppl 3:S16 Breast Cancer ResJournal
Breast Cancer ResearchDOI
10.1186/bcr2435PubMed ID
20030867Type
ArticleLanguage
enISSN
1465-542Xae974a485f413a2113503eed53cd6c53
10.1186/bcr2435
Scopus Count
Collections
Related articles
- Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis.
- Authors: Li X, Sun J, Hu S
- Issue date: 2017 Aug
- A genomic ruler to assess oncogenic transition between breast tumor and stroma.
- Authors: Dhage S, Ernlund A, Ruggles K, Axelrod D, Berman R, Roses D, Schneider RJ
- Issue date: 2018
- Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer.
- Authors: Raphael J, Gong IY, Nofech-Mozes S, Bartlett J, Nafisi H, Verma S
- Issue date: 2016 Jun
- Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
- Authors: Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP
- Issue date: 2011 Jul 8
- Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
- Authors: Sjöberg E, Augsten M, Bergh J, Jirström K, Östman A
- Issue date: 2016 May 10